Logo 1 Logo 2

Clinical Trial Details

Trial ID: L3247
Source ID: NCT00157586
Associated Drug: Delapril, Delapril-Manidipine Fixed Combination
Title: Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND)
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Type 2 Diabetes
Interventions: DRUG: Delapril, Delapril-Manidipine Fixed combination
Outcome Measures: Primary: The rate of decline of glomerular filtration rate (GFR).GFR is measured at baseline,and at 6,12,18,24,30 and 36 months after randomization | Secondary: Major cardiovascular events
Sponsor/Collaborators: Sponsor: Mario Negri Institute for Pharmacological Research
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 342
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: DIAGNOSTIC
Start Date: 2002-02
Completion Date: 2008-06
Results First Posted:
Last Update Posted: 2015-04-09
Locations: ASL of Ponte San Pietro - Diabetologic Unit, Ponte San Pietro, Bergamo, 24036, Italy|Clinical Research Center for Rare Diseases, Ranica, Bergamo, 24020, Italy|Hospital of Romano di Lombardia - Diabetologic Unit, Romano di Lombardia, Bergamo, 24058, Italy|Hospital " Bolognini " - Medicine Unit, Seriate, Bergamo, 24068, Italy|Hospital " Treviglio Caravaggio" - Diabetologic Unit, Treviglio, Bergamo, 24128, Italy|Humanitas Institute - Endocrinology and Diabetologic Unit, Rozzano, Milano, 20089, Italy|Hospital "Ospedali Riuniti di Bergamo" - Diabetologic Unit, Bergamo, 24128, Italy|Department of Endocrinolgy, Diabetes and Metabolic Disease - University Medical Center, Lubiana, Slovenia
URL: https://clinicaltrials.gov/show/NCT00157586